SCHEMBL30622656

SCHEMBL30622656

O=C(O)n1cnc2cnccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.39
LTA4H P09960 1/20 0.38
ASAH1 Q13510 2/20 0.38
ALDH1A1 P00352 3/20 0.37
KMT2A Q03164 4/20 0.36
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
ATM Q13315 1/20 0.35
HTT P42858 1/20 0.35
MET P08581 1/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
KDM6B O15054 1/20 0.34
KDM4A O75164 1/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34
KDM4D Q6B0I6 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5030414 0.84 FGFR1 (0.46) FGFR1SMN1; SMN2LTA4HASAH1ALDH1A1
SCHEMBL31229358 0.82 KMT2A (0.55) FGFR1SMN1; SMN2LTA4HASAH1ALDH1A1
SCHEMBL4910691 0.80 FGFR1 (0.43) FGFR1SMN1; SMN2LTA4HASAH1ALDH1A1
SCHEMBL27599900 0.80 FGFR1 (0.43) FGFR1SMN1; SMN2LTA4HASAH1ALDH1A1
SCHEMBL857765 0.76 SMN1; SMN2 (0.61) SMN1; SMN2ASAH1ALDH1A1KMT2AHTT
SCHEMBL15156816 0.75 FGFR1 (0.47) FGFR1SMN1; SMN2LTA4HMETKDM4E
SCHEMBL14428845 0.75 FGFR1 (0.38) FGFR1LTA4HASAH1ALDH1A1JAK2
SCHEMBL29795658 0.74 ASAH1 (0.63) FGFR1SMN1; SMN2ASAH1ALDH1A1KMT2A
SCHEMBL16822326 0.70 KMT2A (0.49) FGFR1SMN1; SMN2ASAH1ALDH1A1KMT2A
SCHEMBL16197154 0.70 SIRT3 (0.36) FGFR1SMN1; SMN2LTA4HASAH1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090348-A1 THE USE OF SON OF SEVENLESS (SOS) INHIBITOR COMPOUNDS SUCH AS 7-SUBSTITUTED BENZOFURANS TO TREAT CANCER Mirati Therapeutics, Inc. (US) 2026-04-30 WO disclosed
EP-4531838-A1 IMIDAZOPYRIDINE AND OXAZOLOPYRIDINE DERIVATIVES AND ANALOGS THEREOF, METHODS OF PREPARATION THEREOF, METHODS OF HIF-1/2A PATHWAY INHIBITION, AND INDUCTION OF FERROPTOSIS Kuda Therapeutics, Inc. (US) 2025-04-09 EP disclosed
WO-2023234970-A1 IMIDAZOPYRIDINE AND OXAZOLOPYRIDINE DERIVATIVES AND ANALOGS THEREOF, METHODS OF PREPARATION THEREOF, METHODS OF HIF-1/2A PATHWAY INHIBITION, AND INDUCTION OF FERROPTOSIS KUDA Therapeutics, Inc. (US) 2023-12-07 WO disclosed